{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:59:14Z","timestamp":1790837954663,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"SOFAR SpA"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12876-017-0605-x","type":"journal-article","created":{"date-parts":[[2017,4,14]],"date-time":"2017-04-14T01:24:16Z","timestamp":1492133056000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":123,"title":["Lactobacillus casei DG and its postbiotic reduce the inflammatory mucosal response: an ex-vivo organ culture model of post-infectious irritable bowel syndrome"],"prefix":"10.1186","volume":"17","author":[{"given":"Debora","family":"Compare","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Rocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Coccoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debora","family":"Angrisani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costantino","family":"Sgamato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Iovine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Salvatore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Nardone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,14]]},"reference":[{"key":"605_CR1","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.cgh.2012.02.029","volume":"10","author":"RM Lovell","year":"2012","unstructured":"Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol. 2012;10:712\u2013721.e4.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"605_CR2","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/apt.12938","volume":"40","author":"C Canavan","year":"2014","unstructured":"Canavan C, West J, Card T. Review article: the economic impact of the irritable bowel syndrome. Aliment Pharmacol Ther. 2014;40:1023\u201334.","journal-title":"Aliment Pharmacol Ther"},{"key":"605_CR3","first-page":"56","volume":"1","author":"DQ Shih","year":"2007","unstructured":"Shih DQ, Kwan LY. All roads lead to Rome: update on Rome III criteria and new treatment options. Gastroenterol Rep. 2007;1:56\u201365.","journal-title":"Gastroenterol Rep"},{"key":"605_CR4","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1001\/jama.2015.0954","volume":"313","author":"WD Chey","year":"2015","unstructured":"Chey WD, Kurlander J, Eswaran S. Irritable bowel syndrome: a clinical review. JAMA. 2015;313:949\u201358.","journal-title":"JAMA"},{"key":"605_CR5","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/apt.12728","volume":"39","author":"HL Dupont","year":"2014","unstructured":"Dupont HL. Review article: evidence for the role of gut microbiota in irritable bowel syndrome and its potential influence on therapeutic targets. Aliment Pharmacol Ther. 2014;39:1033\u201342.","journal-title":"Aliment Pharmacol Ther"},{"key":"605_CR6","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.cgh.2009.06.031","volume":"7","author":"AC Ford","year":"2009","unstructured":"Ford AC, Spiegel BM, Talley NJ, Moayyedi P. Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2009;7:1279\u201386.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"605_CR7","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nrgastro.2014.40","volume":"11","author":"SM Collins","year":"2014","unstructured":"Collins SM. A role for the gut microbiota in IBS. Nat Rev Gastroenterol Hepatol. 2014;11:497\u2013505.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"605_CR8","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1053\/j.gastro.2009.02.074","volume":"136","author":"R Spiller","year":"2009","unstructured":"Spiller R, Garsed K. Postinfectious irritable bowel syndrome. Gastroenterology. 2009;136:1979\u201388.","journal-title":"Gastroenterology"},{"key":"605_CR9","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.3748\/wjg.v22.i7.2219","volume":"22","author":"E Distrutti","year":"2016","unstructured":"Distrutti E, Monaldi L, Ricci P, Fiorucci S. Gut microbiota role in irritable bowel syndrome:New therapeutic strategies. World J Gastroenterol. 2016;22:2219\u201341.","journal-title":"World J Gastroenterol"},{"key":"605_CR10","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2169\/internalmedicine.54.2710","volume":"54","author":"B Tiequn","year":"2015","unstructured":"Tiequn B, Guanqun C, Shuo Z. Therapeutic effects of Lactobacillus in treating irritable bowel syndrome: a meta-analysis. Intern Med. 2015;54:243\u20139.","journal-title":"Intern Med"},{"key":"605_CR11","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1136\/gutjnl-2011-300971","volume":"61","author":"K Tsilingiri","year":"2012","unstructured":"Tsilingiri K, Barbosa T, Penna G, et al. Probiotic and postbiotic activity in health and disease: comparison on a novel polarised ex-vivo organ culture model. Gut. 2012;61:1007\u201315.","journal-title":"Gut"},{"key":"605_CR12","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.bpg.2004.04.002","volume":"18","author":"RC Spiller","year":"2004","unstructured":"Spiller RC. Inflammation as a basis for functional GI disorders. Best Pract Res Clin Gastroenterol. 2004;18:641\u201361.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"605_CR13","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.biochi.2008.10.017","volume":"91","author":"B Iovine","year":"2009","unstructured":"Iovine B, Nino M, Irace C, et al. Ultraviolet B and A irradiation induces fibromodulin expression in human fibroblasts in vitro. Biochimie. 2009;91:364\u201372.","journal-title":"Biochimie"},{"key":"605_CR14","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/apt.13055","volume":"41","author":"J Sundin","year":"2015","unstructured":"Sundin J, Rangel I, Fuentes S, et al. Altered faecal and mucosal microbial composition in post-infectious irritable bowel syndrome patients correlates with mucosal lymphocyte phenotypes and psychological distress. Aliment Pharmacol Ther. 2015;41:342\u201351.","journal-title":"Aliment Pharmacol Ther"},{"key":"605_CR15","doi-asserted-by":"crossref","first-page":"e0134836","DOI":"10.1371\/journal.pone.0134836","volume":"10","author":"J Sundin","year":"2015","unstructured":"Sundin J, Rangel I, Repsilber D, Brummer RJ. Cytokine response after stimulation with key commensal bacteria differ in post-Infectious Irritable Bowel Syndrome (PI-IBS) patients compared to healthy controls. PLoS One. 2015;10:e0134836.","journal-title":"PLoS One"},{"key":"605_CR16","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1136\/gut.52.4.523","volume":"52","author":"KA Gwee","year":"2003","unstructured":"Gwee KA, Collins SM, Read NW, et al. Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome. Gut. 2003;52:523\u20136.","journal-title":"Gut"},{"key":"605_CR17","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","volume":"11","author":"T Kawai","year":"2010","unstructured":"Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on toll-like receptors. Nat Immunol. 2010;11:373\u201384.","journal-title":"Nat Immunol"},{"key":"605_CR18","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/ajg.2010.438","volume":"106","author":"EK Brint","year":"2011","unstructured":"Brint EK, MacSharry J, Fanning A, et al. Differential expression of toll-like receptors in patients with irritable bowel syndrome. Am J Gastroenterol. 2011;106:329\u201336.","journal-title":"Am J Gastroenterol"},{"key":"605_CR19","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.nut.2014.02.010","volume":"30","author":"C Stevenson","year":"2014","unstructured":"Stevenson C, Blaauw R, Fredericks E, et al. Randomized clinical trial: effect of Lactobacillus plantarum 299 v on symptoms of irritable bowel syndrome. Nutrition. 2014;30:1151\u20137.","journal-title":"Nutrition"},{"key":"605_CR20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/apt.12787","volume":"40","author":"G Sisson","year":"2014","unstructured":"Sisson G, Ayis S, Sherwood RA, Bjarnason I. Randomised clinical trial: a liquid multi-strain probiotic vs. placebo in the irritable bowel syndrome--a 12\u00a0week double-blind study. Aliment Pharmacol Ther. 2014;40:51\u201362.","journal-title":"Aliment Pharmacol Ther"},{"key":"605_CR21","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/nmo.12320","volume":"26","author":"S Ludidi","year":"2014","unstructured":"Ludidi S, Jonkers DM, Koning CJ, et al. Randomized clinical trial on the effect of a multispecies probiotic on visceroperception in hypersensitive IBS patients. Neurogastroenterol Motil. 2014;26:705\u201314.","journal-title":"Neurogastroenterol Motil"},{"key":"605_CR22","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.3109\/00365521.2013.825314","volume":"48","author":"LM Begtrup","year":"2013","unstructured":"Begtrup LM, de Muckadell OB, Kjeldsen J, et al. Long-term treatment with probiotics in primary care patients with irritable bowel syndrome- a randomised, double-blind, placebo controlled trial. Scand J Gastroenterol. 2013;48:1127\u201335.","journal-title":"Scand J Gastroenterol"},{"key":"605_CR23","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/jgh.12322","volume":"29","author":"JS Yoon","year":"2014","unstructured":"Yoon JS, Sohn W, Lee OY, et al. Effect of multispecies probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial. J Gastroenterol Hepatol. 2014;29:52\u20139.","journal-title":"J Gastroenterol Hepatol"},{"key":"605_CR24","first-page":"1","volume":"25","author":"FL Fong","year":"2015","unstructured":"Fong FL, Shah NP, Kirjavainen P, El-Nezami H. Mechanism of action of probiotic bacteria on intestinal and systemic immunities and antigen-presenting cells. Int Rev Immunol. 2015;25:1\u201311.","journal-title":"Int Rev Immunol"},{"key":"605_CR25","doi-asserted-by":"crossref","first-page":"501361","DOI":"10.1155\/2015\/501361","volume":"2015","author":"G Giorgetti","year":"2015","unstructured":"Giorgetti G, Brandimarte G, Fabiocchi F, et al. Interactions between innate immunity, microbiota, and probiotics. J Immunol Res. 2015;2015:501361.","journal-title":"J Immunol Res"},{"key":"605_CR26","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/MOG.0000000000000151","volume":"31","author":"R Frei","year":"2015","unstructured":"Frei R, Akdis M, O'Mahony L. Prebiotics, probiotics, synbiotics, and the immune system: experimental data and clinical evidence. Curr Opin Gastroenterol. 2015;31:153\u20138.","journal-title":"Curr Opin Gastroenterol"},{"key":"605_CR27","doi-asserted-by":"crossref","first-page":"442","DOI":"10.4161\/gmic.20885","volume":"3","author":"K Tsilingiri","year":"2012","unstructured":"Tsilingiri K, Rescigno M. Should probiotics be tested on ex vivo organ culture models? Gut Microbes. 2012;3:442\u20138.","journal-title":"Gut Microbes"},{"key":"605_CR28","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1007\/s10620-015-3607-y","volume":"60","author":"R Shukla","year":"2015","unstructured":"Shukla R, Ghoshal U, Dhole TN, Ghoshal UC. Fecal microbiota in patients with irritable bowel syndrome compared with healthy controls using real-time polymerase chain reaction: an evidence of dysbiosis. Dig Dis Sci. 2015;60:2953\u201362.","journal-title":"Dig Dis Sci"},{"key":"605_CR29","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1136\/gutjnl-2011-301501","volume":"61","author":"IB Jeffery","year":"2012","unstructured":"Jeffery IB, O\u2019Toole PW, \u00d6hman L, et al. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut. 2012;61:997\u20131006.","journal-title":"Gut"},{"key":"605_CR30","first-page":"512","volume":"22","author":"C Tana","year":"2010","unstructured":"Tana C, Umesaki Y, Imaoka A, et al. Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome. Neurogastroenterol Motil. 2010;22:512\u20139.","journal-title":"Neurogastroenterol Motil"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-017-0605-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T22:22:28Z","timestamp":1569018148000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-017-0605-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,14]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["605"],"URL":"https:\/\/doi.org\/10.1186\/s12876-017-0605-x","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,14]]},"article-number":"53"}}